miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A

• Published in: Gene therapy Vol. 29; no. 1-2; p. 28
• Main Authors: Wei, Linlin, Sun, Chaonan, Zhang, Yaotian, Han, Ning, Sun, Shichen
• Format: Journal Article
• Language: English
• Published: England 01.02.2022
• Subjects: Animals; Carcinogenesis - genetics; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms - metabolism; Colonic Neoplasms - pathology; Endothelial Cells - metabolism; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Lymphangiogenesis; Mice; Mice, Nude; MicroRNAs - genetics; MicroRNAs - metabolism; Neovascularization, Pathologic; Proto-Oncogene Proteins c-akt - metabolism; Vascular Endothelial Growth Factor A - genetics; Vascular Endothelial Growth Factor A - metabolism
• ISSN: 1476-5462; 1476-5462
• DOI: 10.1038/s41434-020-0167-3

MicroRNAs (miRNAs) are considered important in the pathogenesis of colon cancer. But the mechanism of their role in colon cancer is still largely unknown. Here, we aimed to explore the function of miR-503-5p in the pathogenesis of colon cancer. This study analyzed miRNA microarray of colon cancer. Then, we performed EdU, CCK-8, flow cytometry, Transwell invasion assays and in vivo assays to explore the exact role of miR-503-5p in colon cancer. We observed considerable downregulation of miR-503-5p expression in colon cancer cells and tissues and significant correlation with the TNM stage, differentiation grade and lymph node metastasis of colon cancer. Overexpression of miR-503-5p promoted the apoptosis and G1 arrest of colon cancer cells, and inhibited migration, proliferation, invasion and colony formation. Interestingly, ectopic miR-503-5p overexpression could significantly inhibit vascular endothelial growth factor (VEGF)-A expression and reduce the activity of a luciferase reporter containing the VEGF-A 3'-untranslated region. Furthermore, overexpressed miR-503-5p in human umbilical vein endothelial cells (HUVECs) and colon cancer cells resulted in lower expression levels of VEGFR-2, and subsequently inhibited AKT signaling pathway. Additionally, overexpression of miR-503-5p suppressed both lymphangiogenesis and angiogenesis in vivo and significantly inhibited the tumorigenicity of HT-29 cells in nude mice. In summary, our study shows downregulation of miR-503-5p at least partially contributes to the tumorigenesis of colon cancer through modulating the angiogenesis and lymphangiogenesis by targeting VEGF-A while stimulating AKT signaling pathways. Therapeutic strategies to restore miR-503-5p in colon cancer could be useful to inhibit tumor progression.